MOS mutation causes female infertility with large polar body oocytes

Gynecol Endocrinol. 2022 Dec;38(12):1158-1163. doi: 10.1080/09513590.2022.2147158. Epub 2022 Nov 20.

Abstract

The Moloney sarcoma oncogene (MOS) encodes a protein serine/threonine kinase and MOS is expressed at high levels in oocytes undergoing meiotic maturation. The MOS/MAPK pathway is normally required for the maintenance of microtubules and chromatin in a metaphasic state during the meiotic divisions. To determine the pathogenic genes in a female infertile patient due to large polar body oocytes, whole-exome sequencing was performed on the patient and available family members. We identified a novel homozygous missense mutation c.591T > G in MOS. Bioinformatics analysis showed that the mutation is harmful. These findings suggest that MOS mutation results in oocytes with a large polar body and poor embryonic development in patients. The MOS variant may regulate oocyte asymmetric division by MAPK/WAVE2/Arp2/3/actin signaling pathway. This will help to understand the comprehensive role of MOS in early human reproductive process and provide genetic markers for future genetic counseling for more individualized treatments.

Keywords: Infertility; MOS; large polar body; meiosis; 不孕; 减数分裂; 大极体; 莫洛尼肉瘤癌基因.

MeSH terms

  • Female
  • Humans
  • Infertility, Female* / metabolism
  • Meiosis
  • Mutation
  • Oocytes / physiology
  • Polar Bodies
  • Proto-Oncogene Proteins c-mos / genetics
  • Proto-Oncogene Proteins c-mos / metabolism
  • Sarcoma* / metabolism

Substances

  • Proto-Oncogene Proteins c-mos